Clinical trial
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
NCT01589198 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
- Lead sponsor
- National Jewish Health
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- June 30, 2016
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.